sodium fluoride has been researched along with Blood Pressure, High in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study, we investigated the protective effects of the methanol extract of Azadirachta indica (AI) against sodium fluoride (NaF)-induced hypertension and genotoxicity in rats." | 7.88 | Ameliorative effect of Azadirachta indica on sodium fluoride-induced hypertension through improvement of antioxidant defence system and upregulation of extracellular signal regulated kinase 1/2 signaling. ( Adedapo, AA; Adejumobi, OA; Ajibade, TO; Alaba, BA; Asenuga, ER; Ola-Davies, OE; Omóbòwálé, TO; Oyagbemi, AA; Yakubu, MA, 2018) |
| " This finding was concurrent with significantly increased serum bioavailability of nitric oxide in the hypertensive rats treated with L-arginine and lisinopril." | 5.91 | L-arginine and lisinopril supplementation protects against sodium fluoride-induced nephrotoxicity and hypertension by suppressing mineralocorticoid receptor and angiotensin-converting enzyme 3 activity. ( Adedapo, AA; Adedapo, AD; Adejumobi, OA; Adetona, MO; Ajibade, TO; Aro, AO; Awodele, OA; Kayoka-Kabongo, PN; McGaw, LJ; Nkadimeng, SM; Oguntibeju, OO; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Tijani, MO; Yakubu, MA, 2023) |
| "Hypertension is one of the silent killers in the world with high mortality and morbidity." | 5.48 | Quercetin attenuates hypertension induced by sodium fluoride via reduction in oxidative stress and modulation of HSP 70/ERK/PPARγ signaling pathways. ( Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Arojojoye, OA; Asenuga, ER; Falayi, OO; Hassan, FO; Ochigbo, GO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018) |
| "Rutin co-treatment with NaF normalized blood pressure, lowered Kim-1 and NF-κB expressions, and improved nitric oxide bioavailability." | 5.48 | Ameliorative effect of Rutin on sodium fluoride-induced hypertension through modulation of Kim-1/NF-κB/Nrf2 signaling pathway in rats. ( Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Asenuga, ER; Ayodeji, F; Falayi, OO; Hassan, FO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018) |
| " Group A was the control group and received normal saline, Group B was exposed to NaF at 300 ppm (300 mg/L) in drinking water daily for a week, Groups C and D were exposed to 300 ppm (300 mg/L) of NaF and coadministered with Luteolin orally daily at a dosage of 100 mg/kg and 200 mg/kg for the same time point." | 5.48 | Luteolin-mediated Kim-1/NF-kB/Nrf2 signaling pathways protects sodium fluoride-induced hypertension and cardiovascular complications. ( Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Asenuga, ER; Falayi, OO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018) |
| " In this study, we investigated the protective effects of the methanol extract of Azadirachta indica (AI) against sodium fluoride (NaF)-induced hypertension and genotoxicity in rats." | 3.88 | Ameliorative effect of Azadirachta indica on sodium fluoride-induced hypertension through improvement of antioxidant defence system and upregulation of extracellular signal regulated kinase 1/2 signaling. ( Adedapo, AA; Adejumobi, OA; Ajibade, TO; Alaba, BA; Asenuga, ER; Ola-Davies, OE; Omóbòwálé, TO; Oyagbemi, AA; Yakubu, MA, 2018) |
| "The aim of this study was to correlate linear (18)F-sodium fluoride accumulation in the femoral arteries as a measure of diffuse mineral deposition in medial elastocalcinosis with cardiovascular risk factors (RFs) and calcified plaque burden (CPB)." | 3.79 | Association of linear ¹⁸F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors: a PET/CT study. ( Bannas, P; Busch, JD; Derlin, T; Herrmann, J; Janssen, T; Mester, J; Münster, S; Treszl, A; Veldhoen, S, 2013) |
| " Since, losartan, an AT1 receptor antagonist, has been shown to attenuate the L-NAME-induced increase in blood pressure, we undertook the present studies to evaluate whether losartan-induced decreased blood pressure in this model of hypertension is associated with attenuation of enhanced expression of Gi proteins and adenylyl cyclase signalling." | 3.72 | Losartan-induced attenuation of blood pressure in L-NAME hypertensive rats is associated with reversal of the enhanced expression of Gi alpha proteins. ( Anand-Srivastava, MB; Hashim, S, 2004) |
| "Xerostomia is a common chronic health condition that affects a great number of adults and significantly deteriorates quality of life, such that treatment is necessary." | 2.77 | Evaluation of the efficacy of two mouthrinses formulated for the relief of xerostomia of diverse origin in adult subjects. ( Espinoza, I; Lozano, C; Morales-Bozo, I; Ortega-Pinto, A; Plaza, A; Rojas, G; Soto, L; Urzúa, B, 2012) |
| " This finding was concurrent with significantly increased serum bioavailability of nitric oxide in the hypertensive rats treated with L-arginine and lisinopril." | 1.91 | L-arginine and lisinopril supplementation protects against sodium fluoride-induced nephrotoxicity and hypertension by suppressing mineralocorticoid receptor and angiotensin-converting enzyme 3 activity. ( Adedapo, AA; Adedapo, AD; Adejumobi, OA; Adetona, MO; Ajibade, TO; Aro, AO; Awodele, OA; Kayoka-Kabongo, PN; McGaw, LJ; Nkadimeng, SM; Oguntibeju, OO; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Tijani, MO; Yakubu, MA, 2023) |
| "Hypertension is one of the silent killers in the world with high mortality and morbidity." | 1.48 | Quercetin attenuates hypertension induced by sodium fluoride via reduction in oxidative stress and modulation of HSP 70/ERK/PPARγ signaling pathways. ( Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Arojojoye, OA; Asenuga, ER; Falayi, OO; Hassan, FO; Ochigbo, GO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018) |
| "Rutin co-treatment with NaF normalized blood pressure, lowered Kim-1 and NF-κB expressions, and improved nitric oxide bioavailability." | 1.48 | Ameliorative effect of Rutin on sodium fluoride-induced hypertension through modulation of Kim-1/NF-κB/Nrf2 signaling pathway in rats. ( Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Asenuga, ER; Ayodeji, F; Falayi, OO; Hassan, FO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018) |
| " Group A was the control group and received normal saline, Group B was exposed to NaF at 300 ppm (300 mg/L) in drinking water daily for a week, Groups C and D were exposed to 300 ppm (300 mg/L) of NaF and coadministered with Luteolin orally daily at a dosage of 100 mg/kg and 200 mg/kg for the same time point." | 1.48 | Luteolin-mediated Kim-1/NF-kB/Nrf2 signaling pathways protects sodium fluoride-induced hypertension and cardiovascular complications. ( Adedapo, AA; Adejumobi, OA; Afolabi, JM; Ajibade, TO; Asenuga, ER; Falayi, OO; Ogunpolu, BS; Ola-Davies, OE; Omobowale, TO; Oyagbemi, AA; Saba, AB; Yakubu, MA, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (18.75) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 8 (50.00) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Ajibade, TO | 6 |
| Awodele, OA | 1 |
| Tijani, MO | 1 |
| Adejumobi, OA | 5 |
| Adetona, MO | 1 |
| Oyagbemi, AA | 6 |
| Adedapo, AD | 1 |
| Omobowale, TO | 6 |
| Aro, AO | 1 |
| Ola-Davies, OE | 5 |
| Saba, AB | 4 |
| Adedapo, AA | 6 |
| Nkadimeng, SM | 1 |
| McGaw, LJ | 1 |
| Kayoka-Kabongo, PN | 1 |
| Oguntibeju, OO | 1 |
| Yakubu, MA | 6 |
| Alaba, BA | 1 |
| Asenuga, ER | 5 |
| Arojojoye, OA | 1 |
| Afolabi, JM | 3 |
| Ogunpolu, BS | 4 |
| Falayi, OO | 3 |
| Hassan, FO | 2 |
| Ochigbo, GO | 1 |
| Ayodeji, F | 1 |
| Janssen, T | 1 |
| Bannas, P | 1 |
| Herrmann, J | 1 |
| Veldhoen, S | 1 |
| Busch, JD | 1 |
| Treszl, A | 1 |
| Münster, S | 1 |
| Mester, J | 1 |
| Derlin, T | 1 |
| Picco, DC | 1 |
| Delbem, AC | 1 |
| Sassaki, KT | 1 |
| Sumida, DH | 1 |
| Antoniali, C | 1 |
| Adejumobi, AO | 1 |
| Ige, TM | 1 |
| Morales-Bozo, I | 1 |
| Rojas, G | 1 |
| Ortega-Pinto, A | 1 |
| Espinoza, I | 1 |
| Soto, L | 1 |
| Plaza, A | 1 |
| Lozano, C | 1 |
| Urzúa, B | 1 |
| Hashim, S | 1 |
| Anand-Srivastava, MB | 1 |
| Chatelain, P | 1 |
| Robberecht, P | 1 |
| De Neef, P | 1 |
| Camus, JC | 1 |
| Christophe, J | 1 |
| Chiu, TH | 1 |
| Chatziantoniou, C | 1 |
| Ruan, X | 1 |
| Arendshorst, WJ | 1 |
| Grekin, RJ | 1 |
| Dumont, CJ | 1 |
| Vollmer, AP | 1 |
| Watts, SW | 1 |
| Webb, RC | 1 |
| Yoshikawa, H | 1 |
| Fukuda, K | 1 |
| Baba, A | 1 |
| Nishio, H | 1 |
| Ueyama, T | 1 |
| Yoshikawa, A | 1 |
| Kuchii, M | 1 |
| Nishio, I | 1 |
| Masuyama, Y | 1 |
| Nelson, KM | 1 |
| Shepherd, RE | 1 |
| Spitzer, JA | 1 |
1 trial available for sodium fluoride and Blood Pressure, High
| Article | Year |
|---|---|
Evaluation of the efficacy of two mouthrinses formulated for the relief of xerostomia of diverse origin in adult subjects.
Topics: Adult; Aloe; Arthritis; Burning Mouth Syndrome; Cetylpyridinium; Citric Acid; Cross-Over Studies; De | 2012 |
15 other studies available for sodium fluoride and Blood Pressure, High
| Article | Year |
|---|---|
L-arginine and lisinopril supplementation protects against sodium fluoride-induced nephrotoxicity and hypertension by suppressing mineralocorticoid receptor and angiotensin-converting enzyme 3 activity.
Topics: Angiotensins; Animals; Antioxidants; Arginine; Blood Pressure; Dietary Supplements; Humans; Hyperten | 2023 |
Ameliorative effect of Azadirachta indica on sodium fluoride-induced hypertension through improvement of antioxidant defence system and upregulation of extracellular signal regulated kinase 1/2 signaling.
Topics: Animals; Antioxidants; Azadirachta; Blood Pressure; Drinking Water; Heart; Hypertension; Kidney; Mal | 2018 |
Quercetin attenuates hypertension induced by sodium fluoride via reduction in oxidative stress and modulation of HSP 70/ERK/PPARγ signaling pathways.
Topics: Animals; Antioxidants; Blood Pressure; Glutathione; HSP70 Heat-Shock Proteins; Humans; Hypertension; | 2018 |
Ameliorative effect of Rutin on sodium fluoride-induced hypertension through modulation of Kim-1/NF-κB/Nrf2 signaling pathway in rats.
Topics: Animals; Antioxidants; Blood Pressure; Cell Adhesion Molecules; Hypertension; Male; NF-E2-Related Fa | 2018 |
Luteolin-mediated Kim-1/NF-kB/Nrf2 signaling pathways protects sodium fluoride-induced hypertension and cardiovascular complications.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Catalase; Drug Administration Schedule; Electrocar | 2018 |
Association of linear ¹⁸F-sodium fluoride accumulation in femoral arteries as a measure of diffuse calcification with cardiovascular risk factors: a PET/CT study.
Topics: Adult; Aged; Aged, 80 and over; Calcinosis; Cardiovascular Diseases; Diabetes Complications; Female; | 2013 |
The effect of chronic treatment with fluoride on salivary activity, tooth, and bone in spontaneously hypertensive rats (SHR).
Topics: Amylases; Animals; Calcium; Femur; Hardness; Hypertension; Incisor; Proteins; Rats; Rats, Inbred SHR | 2014 |
Sodium fluoride induces hypertension and cardiac complications through generation of reactive oxygen species and activation of nuclear factor kappa beta.
Topics: Animals; Biomarkers; Cariostatic Agents; Hypertension; Kidney; Male; Malondialdehyde; Myocardium; NF | 2017 |
Losartan-induced attenuation of blood pressure in L-NAME hypertensive rats is associated with reversal of the enhanced expression of Gi alpha proteins.
Topics: Adenylyl Cyclases; Animals; Antihypertensive Agents; Blood Pressure; Colforsin; Disease Models, Anim | 2004 |
Thermodependence of basal and stimulated cardiac adenylate cyclase activity in normotensive and spontaneously hypertensive rats.
Topics: Adenylyl Cyclases; Animals; Cell Membrane; Guanylyl Imidodiphosphate; Hypertension; Kinetics; Magnes | 1983 |
Age-dependent changes in the myocardial adenylate cyclase of normotensive and spontaneously hypertensive rat.
Topics: Adenylyl Cyclases; Aging; Animals; Body Weight; Hypertension; Isoproterenol; Male; Microsomes; Muscl | 1981 |
Defective G protein activation of the cAMP pathway in rat kidney during genetic hypertension.
Topics: Angiotensin II; Animals; Blood Pressure; Cholera Toxin; Cyclic AMP; Fenoldopam; GTP-Binding Proteins | 1995 |
Mechanisms in the pressor effects of hepatic portal venous fatty acid infusion.
Topics: Acetylcholine; Aldosterone; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pre | 1997 |
Deficient activity of nucleotide binding regulatory protein coupled with PGE2 receptor in renal medulla of spontaneously hypertensive rats.
Topics: Adenylyl Cyclases; Animals; Colforsin; Dinoprostone; GTP-Binding Proteins; Hypertension; Kidney Medu | 1990 |
Lipolysis and beta-adrenergic receptor binding on adipocytes of spontaneously hypertensive rats.
Topics: Adipose Tissue; Animals; Cyclic AMP; Dihydroalprenolol; Hypertension; Isoproterenol; Lipolysis; Rats | 1987 |